FMBTD
AIMT

First Midwest Bank Trust Division’s Aimmune Therapeutics AIMT Stock Holding History

First Midwest Bank Trust Division’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-8,082
Closed -$278K – 374
2020
Q3 		$278K Sell
8,082
-82,771
-91% -$1.76M 0.04% 305
2020
Q2 		$1.52M Buy
90,853
+5,851
+7% +$99.3K 0.25% 104
2020
Q1 		$1.23M Buy
+85,002
New +$2.17M 0.22% 113

First Midwest Bank Trust Division's AIMT Position: Q4 2020 in Review

First Midwest Bank Trust Division sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 8,082 shares — an estimated $278K sold.

First Midwest Bank Trust Division first reported a position in AIMT in Q1 2020 and held it in 3 quarters. The position peaked at $1.52M in Q2 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • First Midwest Bank Trust Division reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • First Midwest Bank Trust Division sold 8,082 Aimmune Therapeutics shares in Q4 2020, an estimated $278K.
  • First Midwest Bank Trust Division first reported a position in Aimmune Therapeutics in Q1 2020 and held it in 3 quarters.
  • First Midwest Bank Trust Division's Aimmune Therapeutics position peaked at $1.52M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on First Midwest Bank Trust Division's 13F filing for Q4 2020, filed 14 Jan 2021.